Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array
Ws. Tung et al., Simultaneous analysis of 1176 gene products in normal human aorta and abdominal aortic aneurysms using a membrane-based complementary DNA expression array, J VASC SURG, 34(1), 2001, pp. 143-150
Citations number
46
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background: A number of changes in gene expression have been described in a
bdominal aortic aneurysms (AAAs), but the spectrum of molecular alterations
in this disease is un]known. The purpose of this study was to characterize
the expression of approximately 1000 gene products in human AAA tissue and
to compare the profile of genes expressed in AAAs with that observed in no
rmal aorta.
Materials and Methods Total RNA was isolated from abdominal aortic wall tis
sues (4 AAAs and 4 normal aortas), and array-specific [P-32]-labeled comple
mentary DNA (cDNA) probes were created with reverse transcription. The cDNA
probes were hybridized with nylon membranes containing an array of 1176 cD
NA clones (AtlasArray Human 1.2 I; Clontech, Pale Alto, Calif), and autorad
iographs were scanned to identify the patterns of gene expression character
istic of each tissue type. Densitometric analysis was used to standardize t
he expression of individual genes to a panel of housekeeping controls, and
differential gene expression was defined by a signal ratio of at least 2:1.
Results: One hundred forty-five (12.3%) of the 1176 genes were consistently
expressed in aortic tissue. Thymosin beta -4 was the most abundant of 101
transcripts detected in both AAAs and normal aorta, whereas 44 genes exhibi
ted differential patterns of expression (39 predominant in AAAs and 5 in no
rmal aorta). Densitometric analysis confirmed differences in expression for
20 of these gene products between AAAs and normal aorta, with the greatest
increases seen for myeloid cell nuclear differentiation antigen (31-fold),
cathepsin H (30-fold), platelet-derived growth factor-A (23-fold), apolipo
protein E (13-fold), gelatinase B/matrix metalloproteinase-9 (12-fold), and
interleukin-8 (11-fold). The only gene products substantially decreased in
AAAs were myosin light chain kinase (39-fold) and beta -1 integrin (twofol
d). AAA tissues thereby exhibited a distinct pattern of gene expression ref
lecting chronic inflammation, extracellular matrix degradation, atheroscler
osis, and smooth muscle cell depletion.
Conclusion: cDNA expression arrays provide a powerful new approach to help
identify the molecular mechanisms responsible for aneurysmal degeneration.
Further studies will be needed to elucidate the functional and pathophysiol
ogic significance of the individual genes that exhibit altered levels of ex
pression in AAA tissue.